Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00898482
What this trial is testing

Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00003591
What this trial is testing

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Radiation Therapy Oncology Group 122
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Study completedNCT00003810
What this trial is testing

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00005843
What this trial is testing

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00028834
What this trial is testing

Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00100815
What this trial is testing

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00462852
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Hull University Teaching Hospitals NHS Trust 120
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Study completedNCT00085371
What this trial is testing

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Study completedNCT00112528
What this trial is testing

Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 53
Testing effectiveness (Phase 2)Study completedNCT01234935
What this trial is testing

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+5 more
Translational Oncology Research International 8
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT01227018
What this trial is testing

PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
Vanderbilt-Ingram Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00383760
What this trial is testing

Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerRecurrent Pancreatic Cancer+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00053222
What this trial is testing

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine

Who this might be right for
Pancreatic Cancer
University of Chicago 13
Early research (Phase 1)UnknownNCT00010270
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University Hospital Freiburg 50
Next Page